Sermorelin vs HGH 191AA: What’s the Difference?
The main difference between Sermorelin and HGH 191AA is mechanism: Sermorelin is studied for endogenous gh-release research — Classic GHRH analog (29 amino acids). HGH 191AA is studied for reference growth hormone research — Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis.
Stimulating native release vs direct GH delivery.
Key differences between Sermorelin and HGH 191AA
- •Mechanism: Sermorelin — Classic GHRH analog (29 amino acids). HGH 191AA — Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis.
- •Primary research focus: Sermorelin is studied for endogenous gh-release research; HGH 191AA is studied for reference growth hormone research.
- •Overlap: the two compounds share muscle growth & performance.
- •Discussion context: Sermorelin is most often discussed alongside endogenous gh-release research, while HGH 191AA centres on reference growth hormone research.
| Attribute | Sermorelin GHRH(1-29) | HGH 191AA Recombinant Human Growth Hormone |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Best known for | Endogenous GH-release research | Reference growth hormone research |
| Mechanism of action | Classic GHRH analog (29 amino acids). Mild, well-tolerated GH release. | Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis. |
| Human research | Moderate | Not catalogued |
| Animal research | Moderate | Not catalogued |
| Mechanistic research | Established | Not catalogued |
| Study cadence cited | Daily before bed (commonly 5 nights on, 2 off) | — |
| In plain English | The original GH peptide. Sermorelin is shorter-acting and milder than CJC-1295 — researchers consider it the gentle introduction to GH peptide research. | The real thing. Where peptides stimulate the body to make more GH, HGH 191AA is the GH molecule itself. |
| How it works | Stimulates pituitary GH release by binding the GHRH receptor. | Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis. |
| Researchers study | Age-related GH decline, body composition, sleep, and pediatric GH deficiency. | GH deficiency, body composition, recovery, and longevity. |
| Internet discussion | Older audience favors it for being well-studied with a long history. | Long-running anti-aging discussion topic. |
Mechanism and research evidence, side by side
How Sermorelin and HGH 191AA differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
Sermorelin
Classic GHRH analog (29 amino acids). Mild, well-tolerated GH release.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Moderate
- Animal research
- Moderate
- Mechanistic research
- Established
Anti-aging, sleep quality, recovery, mild GH support
Sermorelin
Endogenous GH-release research
The original GH peptide. Sermorelin is shorter-acting and milder than CJC-1295 — researchers consider it the gentle introduction to GH peptide research.
Stimulates pituitary GH release by binding the GHRH receptor.
Age-related GH decline, body composition, sleep, and pediatric GH deficiency.
Older audience favors it for being well-studied with a long history.
Sermorelin is the original GHRH analog with the longest research history in GH peptide work.
HGH 191AA
Reference growth hormone research
The real thing. Where peptides stimulate the body to make more GH, HGH 191AA is the GH molecule itself.
Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis.
GH deficiency, body composition, recovery, and longevity.
Long-running anti-aging discussion topic.
HGH 191AA is recombinant human growth hormone — the reference standard for GH research.